Skip to contentW
Windtree Therapeutics Inc
W
WINTWindtree Therapeutics Inc Q1 2016 · 10-Q
Revenue$75.00K$75.00K−60.7% vs Q1 2015 Net Income-$13.90M-$13.90MN/M vs Q1 2015 EPS Diluted-$1.70-$1.70N/M vs Q1 2015 Operating Income-$13,942,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Windtree Therapeutics Inc · CIK 946486 · Engraved from SEC EDGAR
Free Cash Flowderived-$9,322,000N/M Margins · derivedOperating margin-18589.3%−12739.6 pt vs Q1 2015
Net margin-18534.7%−12158.2 pt vs Q1 2015
ended Mar 31, 2016 · filed May 12, 2016 · 42 d after period end